Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis.

Por Lipponen, P., Eskelinen, M.
Publicado em 1994

Cell proliferation of transitional cell bladder tumours determined by PCNA/cyclin immunostaining and its prognostic value.

Por Lipponen, P. K., Eskelinen, M. J.
Publicado em 1992

Expression of tumour-suppressor gene Rb, apoptosis-suppressing protein Bcl-2 and c-Myc have no independent prognostic value in renal adenocarcinoma.

Por Lipponen, P., Eskelinen, M., Syrjänen, K.
Publicado em 1995

Nucleolar organiser regions (AgNORs) as predictors in transitional cell bladder cancer.

Por Lipponen, P. K., Eskelinen, M. J., Nordling, S.
Publicado em 1991

The growth pattern and microvasculature of pancreatic tumours induced with cultured carcinoma cells

Por Mäkinen, K, Loimas, S, Nuutinen, P, Eskelinen, M, Alhava, E
Publicado em 2000

α-Catenin expression has prognostic value in local and locally advanced prostate cancer

Por Aaltomaa, S, Lipponen, P, Ala-Opas, M, Eskelinen, M, Kosma, V-M
Publicado em 1999

Receiver operating characteristic (ROC) curve analysis of the tumour markers CEA, CA 50 and CA 242 in pancreatic cancer; results from a prospective study.

Por Pasanen, P. A., Eskelinen, M., Partanen, K., Pikkarainen, P., Penttilä, I., Alhava, E.
Publicado em 1993

A prospective study of serum tumour markers carcinoembryonic antigen, carbohydrate antigens 50 and 242, tissue polypeptide antigen and tissue polypeptide specific antigen in the di...

Por Pasanen, P. A., Eskelinen, M., Partanen, K., Pikkarainen, P., Penttilä, I., Alhava, E.
Publicado em 1994

Clinical evaluation of a new serum tumour marker CA 242 in pancreatic carcinoma.

Por Pasanen, P. A., Eskelinen, M., Partanen, K., Pikkarainen, P., Penttilä, I., Alhava, E.
Publicado em 1992

Expression of cyclins A and D and p21((waf1/cip1)) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival

Por Aaltomaa, S, Lipponen, P, Ala-Opas, M, Eskelinen, M, Syrjänen, K, Kosma, V-M
Publicado em 1999

Expression of transcription factor AP-2 in colorectal adenomas and adenocarcinomas; comparison of immunohistochemistry and in situ hybridisation

Por Ropponen, K, Kellokoski, J, Pirinen, R, Moisio, K, Eskelinen, M, Alhava, E, Kosma, V
Publicado em 2001

Reduced expression of alpha catenin is associated with poor prognosis in colorectal carcinoma.

Por Ropponen, K M, Eskelinen, M J, Lipponen, P K, Alhava, E M, Kosma, V M
Publicado em 1999

Mitotic rate and S-phase fraction as prognostic factors in stage I cutaneous malignant melanoma.

Por Karjalainen, J. M., Eskelinen, M. J., Nordling, S., Lipponen, P. K., Alhava, E. M., Kosma, V. M.
Publicado em 1998

Measurement of prostate-specific antigen in detection of benign or malignant breast disease in women

Por Romppanen, J, Keskikuru, R, Kataja, V, Eskelinen, M, Kosma, V-M, Savolainen, K, Uusitupa, M, Mononen, I
Publicado em 1999

p21(WAF1) expression in invasive breast cancer and its association with p53, AP-2, cell proliferation, and prognosis

Por Pellikainen, M J, Pekola, T T, Ropponen, K M, Kataja, V V, Kellokoski, J K, Eskelinen, M J, Kosma, V-M
Publicado em 2003

Prognostic factors in gastric cancer: the value of vascular invasion, mitotic rate and lymphoplasmacytic infiltration.

Por Setälä, L. P., Kosma, V. M., Marin, S., Lipponen, P. K., Eskelinen, M. J., Syrjänen, K. J., Alhava, E. M.
Publicado em 1996

p21/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis

Por Ropponen, K M, Kellokoski, J K, Lipponen, P K, Pietiläinen, T, Eskelinen, M J, Alhava, E M, Kosma, V-M
Publicado em 1999

Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate

Por Setälä, L P, Tammi, M I, Tammi, R H, Eskelinen, M J, Lipponen, P K, Ågren, U M, Parkkinen, J, Alhava, E M, Kosma, V-M
Publicado em 1999

Failure in post-transcriptional processing is a possible inactivation mechanism of AP-2 α in cutaneous melanoma

Por Karjalainen, J M, Kellokoski, J K, Mannermaa, A J, Kujala, H E, Moisio, K I, Mitchell, P J, Eskelinen, M J, Alhava, E M, Kosma, V M
Publicado em 2000